US Food and Drug Administration

fda-issues-response-letters-as-biopharma-sector-sees-key-advances

FDA Issues Response Letters as Biopharma Sector Sees Key Advances

Editorial 7 February, 2026

The US Food and Drug Administration (FDA) recently issued significant updates affecting several pharmaceutical...

fda-approves-new-treatments-and-issues-crls-in-key-healthcare-developments

FDA Approves New Treatments and Issues CRLs in Key Healthcare Developments

Editorial 3 January, 2026

The week of December 28, 2025, saw significant advancements in the healthcare sector, marked...

bayer-secures-us-approval-for-hyrnuo-lung-cancer-treatment

Bayer Secures US Approval for Hyrnuo Lung Cancer Treatment

Editorial 20 November, 2025

Bayer AG has received approval from the US Food and Drug Administration (FDA) for...

fda-listening-session-sparks-insights-for-cell-and-gene-therapy

FDA Listening Session Sparks Insights for Cell and Gene Therapy

Editorial 3 October, 2025

The US Food and Drug Administration (FDA) hosted a public listening session on September...

former-fda-chief-challenges-food-safety-standards-in-bold-move

Former FDA Chief Challenges Food Safety Standards in Bold Move

Editorial 8 August, 2025

Dr. David Kessler, a former commissioner of the US Food and Drug Administration (FDA),...